Physiological parameters for oral delivery and in vitro testing
about
A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo dataA Janus Mucoadhesive and Omniphobic Device for Gastrointestinal RetentionRapid Kinetics of Size and pH-Dependent Dissolution and Aggregation of Silver Nanoparticles in Simulated Gastric Fluid.Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HClMechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatusImproved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.Reevaluation and Classification of Duodenal Lesions in B6C3F1 Mice and F344 Rats from 4 Studies of Hexavalent Chromium in Drinking Water.A Mouse Intra-Intestinal Infusion Model and its Application to the Study of Nanoparticle Distribution.Assessment of gastrointestinal motor functions by MRI: a comprehensive review.Inorganic matrices: an answer to low drug solubility problem.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.Drug release from matrix tablets: physiological parameters and the effect of food.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.Current state and challenges in developing oral vaccines.Influence of multi-walled carbon nanotubes on the cognitive abilities of Wistar rats.Development and validation of a new dynamic computer-controlled model of the human stomach and small intestine.Gastrointestinal characterisation and drug solubility determination in animals.NanoClusters surface area allows nanoparticle dissolution with microparticle properties.Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.Development of a continuous dissolution/absorption system--a technical note.The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCRegional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine.Correlating cellulose derivative intrinsic viscosity with mechanical susceptibility of swollen hydrophilic matrix tablets.The Development of Models Based on Linear and Nonlinear Multivariate Methods to Predict ADME/PK Properties Using Physicochemical Properties of Kinase, Protease Inhibitors, and GPCR Antagonists.Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugsClinicians' prescribing practices for bariatric surgery patients: is there an issue?Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry.Stability of plant virus-based nanocarriers in gastrointestinal fluids.Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models.Student Award for Outstanding Research Winner in the Undergraduate Category for the 2017 Society for Biomaterials Annual Meeting and Exposition, April 5-8, 2017, Minneapolis, Minnesota: Development and characterization of stimuli-responsive hydrogelLow colonic absorption drugs: risks and opportunities in the development of oral extended release products.Feasibility of capsule endoscopy for direct imaging of drug delivery systems in the fasted upper-gastrointestinal tract.Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.Noninvasive vaccination against infectious diseases.A New Approach to Dissolution Testing by UV Imaging and Finite Element SimulationsMultifunctional microspherical magnetic and pH responsive carriers for combination anticancer therapy engineered by droplet-based microfluidics
P2860
Q30578718-0FDEB50D-DEA5-4D2F-884E-1FAED5EDE8C2Q30837039-BECC1233-732C-405A-A4B5-E54E32E44D51Q30843529-D44214C8-947B-4036-BDB2-B4C5AC886093Q33553580-B9B77185-33DC-4EE2-84F1-0B144ADB5DC4Q35854694-84514983-40A4-4D2F-A378-97C681BED348Q36019637-F3BD09F8-44F2-42AD-9B69-84247A11F632Q36232481-C2989408-5C5F-45A1-B287-67C2508D12CDQ36672685-E9F9EE4D-19B0-4EEA-B116-A11E93D5F94CQ37448385-870E82D9-8F62-4DE6-917F-B747DFEA7C56Q37833148-A500ED56-FE35-43E3-8091-F26780524475Q38051672-0F91A480-C30F-4B8E-9083-084FE81FEC90Q38110619-4F68A1C6-177C-4C82-A465-A18E08C35955Q38223664-41F5B1FA-D671-4257-8BA2-7BA9B8F411C8Q38541574-03CFBA65-DB63-4714-8207-1BCF42FF399AQ38922030-1B7E5FA8-2377-49A3-9D37-276B31B34EC3Q39259629-CA38C7CF-98EE-48F7-BD78-89B6E24E3D7CQ39429064-A82EB068-22C3-4757-8ECD-44DD6E017795Q40263997-8038F783-7D3D-4812-B9FB-661867363115Q41622617-45E46B66-49D0-4D58-9B1A-2945071DDC55Q41810733-304A48BB-BA3F-4102-BBE5-7282D3F95CA4Q41823826-09F857FE-642C-4DEE-B3D7-6292B611025BQ41854431-4F4B33F2-3C2F-44C6-A9DE-7F296BB5FE96Q41948835-B3B4B5EC-C65E-4381-9230-FF54C058870FQ41986927-8EA0E624-CECD-4995-9B4B-749FB8DD2727Q42024380-F88CD729-A48B-4F58-92B9-32C8FF792516Q42102051-3277D8E5-2AB8-45EA-AD28-F7B26113A9D7Q42321064-662CAE31-DA8A-4F72-A686-22B76E80B858Q45343457-51E86000-A758-4E5E-9FF0-23DAC6D25086Q46820676-C9DBA0B5-81EA-4E05-A402-D5C72680E998Q47258248-18C53493-5342-4FE5-AB83-8C8621DC9F65Q47338381-B9F8295F-1056-40E9-A4AC-7569D9CBDD21Q47577583-EBB8ED08-8C9E-4335-9446-65F3EA97EFB0Q49500092-0BF91A55-6080-4809-9B93-5EE0283A53F7Q51326782-E141FF1A-AE37-4C7D-B25A-C322EC3D4FBDQ51372033-808575B5-C415-4F6E-9957-EFE4ED90A1E1Q52362750-AAC82CF7-BC08-44BB-89C1-ACB9B64A960DQ52602778-A633A816-F9B2-4890-8DE6-1C40363C79E9Q58199053-957BE2CD-11A0-44DB-A928-9E0F0F40AD8DQ59189913-A2138E1A-EAE8-4E48-86B5-5E47463C83C2
P2860
Physiological parameters for oral delivery and in vitro testing
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Physiological parameters for oral delivery and in vitro testing
@ast
Physiological parameters for oral delivery and in vitro testing
@en
Physiological parameters for oral delivery and in vitro testing.
@nl
type
label
Physiological parameters for oral delivery and in vitro testing
@ast
Physiological parameters for oral delivery and in vitro testing
@en
Physiological parameters for oral delivery and in vitro testing.
@nl
prefLabel
Physiological parameters for oral delivery and in vitro testing
@ast
Physiological parameters for oral delivery and in vitro testing
@en
Physiological parameters for oral delivery and in vitro testing.
@nl
P2093
P2860
P3181
P356
P1476
Physiological parameters for oral delivery and in vitro testing
@en
P2093
Deanna M. Mudie
Gordon L. Amidon
Gregory E. Amidon
P2860
P304
P3181
P356
10.1021/MP100149J
P407
P577
2010-10-04T00:00:00Z